Q: Hi, I would like to reduce the number of stocks in my portfolio. I have small positions in these 3 stocks. In what order should I sell them and is any worth keeping?
Thanks.
Q: First of all, thanks for the service you provide. I have found it extremely useful since becoming a member. Second, I apologize for the number of stocks covered in the question. If it is too many, please do not respond / post.
Within the last 12 months, I have purchased the above stocks strictly for growth or as momentum plays.
I would like to know which ones you would sell, either because their momentum has likely peaked, or because their share price growth prospects are poor. Please deduct as many credits as required. Thanks
Q: Happy New Year to Everyone at 5i and thanks for all your guidance.
I have just taken profits in XBC (thanks) in my TSFA and would like your purchase a similar small cap growth stock. I already have STC, Well and Pho. Could you please give me 3-4 suggestions.
Thanks
Dave.
I currently own WELL, however I'm looking at at three others in the space, Vitalhub, cloudMD and Think Research.
Please give me an over view of the differentiation between these four.
Also your view, rank, on which of the four will be the best in 5 yrs.
Thx
Q: Do you endorse a tax-loss sale for these three stocks, DXCM, REAL, VHI with the intention to buy back after 30 days? Are there any that you wouldn't buy back and instead use the proceeds on another high growth name such as NVDA, U, GOOS, PINS, MGNI? Sector weighting is not a concern and risk tolerance is high. Thanks.
I need to sell some of my shares in these companies to fund another investment. Of the stocks listed, in what order would you be inclined to sell first? Thank you.
Q: Good morning, could you please rank these 10 small caps that the team has mentioned recently in terms of both opportunity (highest to lowest) and risk (Lowest to highest). I am unfamiliar with DCM but from your comments, and the extremely low PE, I am assuming they owe a few bucks? Could you shed some light on the company? Thx as always for tremendous guidance.
Q: Could you please comment on vital health earning report and future prospects. Is it a hold / sell / or buy more? Could you also comment dynacert hold / sell / buy more)?
Q: I am looking to add your suggestions of Palantir and Pinterest. Can you please rank them with some of my current 5i holdings in terms of growth highest to lowest and risk highest to lowest. These are 1-2 percent fringe plays and I have a balanced portfolio so I am not worried about cap size, geographic location etc. Thanks very much as always for advice.
With 22 tech stocks weighting some 34% of my portfolio, I assume you would recommend that I rationalize my approach for a better diversification, both in my tech sector and in my portfolio as a whole.
To accomplish that, while keeping a strong growth approach, could you indicate which are, in your view, 1) the « must own » stocks, in order of importance 2) those which could be dropped because of « double emploi » or high risk, 3) those missing to properly cover the tech sector ?
Please feel free to use as many credits as you see fit.
Q: In a head-to-head comparison, which small-cap health care stock would you side with? Both have made good acquisitions this year and revenue growth will likely follow. DOC is bigger, but the market cap for VHI is approaching 100M which is a good milestone. Both are soon closing their recent public offerings, which will help with future growth/acquisitions.
Is either one on your radar for adding it to the 5i Growth Portfolio in 2021?
Q: Could you give me your assessment on these three companies please. Would you consider buying any of these today? How would you rate them? How do they stand financially? What are their growth prospects?
Thanks John
Q: Hi Peter and Team,
Can you give me your opinion on VHI,STC, ATGN. Do you thing it is good timing to invest in them or shall wait after the new year. Also, please rank based on risk and opportunity to grow.
Thanks,
Q: Been watching Vitalhub and like what the company is doing. They announced a financing at $2.90 and the stock fell hard on the news. Thinking it be maybe worth a starter position below the $2.90 price point. Would you buy here or wait for things to settle down?
Q: I am looking at buying one of these small caps for 2 to 3 year hold. Would you please compare and contrast each with earnings potential,debt,etc and rank them 1 to 4 ? Thank you.